packageLaronidase

laronidase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Laronidase is an enzyme replacement therapy used to treat mucopolysaccharidosis I, a rare inherited metabolic disorder. It is authorised in the European Union and is an approved medicine, used mainly in specialist care for this rare disease.

Summary written by glm-5.3-flash from Wikidata Q20801774 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:laronidase
ATC codes:A16AB05
DrugBank:DB00090
Wikidata:Q20801774
molar mass:69899.4 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown